[19] This may be the other mechanism of action of Silymarin in the treatment of melasma. Silymarin inhibited l-DOPA oxidation activity of tyrosinase, the rate-limiting melanogenic enzyme ...

hormonal treatment, medical conditions involving the endocrine system (aka, the glands that release hormones into the blood) and stress. Melasma is more apparent in women, compared with men ...